Health

Stelo Will Be First Continuous Glucose Monitor (CGM) Available Without a Prescription

[ad_1]

This story also appears on Everyday Health’s network site Diabetes Daily.

Dexcom, the maker of the G6 and G7 continuous glucose monitor (CGM) systems, has been granted approval to sell America’s first over-the-counter CGM. For the first time, people with (and without) diabetes will be able to track their blood sugar levels around the clock without a doctor’s prescription.

The U.S. Food and Drug Administration (FDA) announced that it had cleared the new system for anyone over 18 who does not use insulin.

 The Stelo will be available in the summer of 2024, according to the manufacturer, vastly increasing the number of Americans eligible to purchase a CGM.

CGM technology, which provides constantly updated blood glucose measurements, was initially developed to treat type 1 diabetes, a condition that requires the administration of insulin and carries a constant risk of dangerously low and high blood sugar levels. In recent years, however, doctors and insurers alike have been more supportive of CGM use in people with type 2 diabetes. Now people with diabetes who do not use insulin — a patient group with little need for alarms and safety features — will have easy access to a CGM made just for them.

The Stelo CGM

The full name of the new device is the Dexcom Stelo Glucose Biosensor System. Last summer, Dexcom’s executive vice president and chief operating officer, Jake Leach, previewed the product for Diabetes Daily.

[ad_2]

Related Articles

Leave a Reply

Back to top button